# FTO-dependent m6A methylation mediates gestational diabetes mellitus-induced offspring cardiac senescent hypertrophy and dysfunction

**Authors:** Wansu Yu, Yong Li, Siyi Jiang, Jia Tian, Shu-Wei Sun, Lubo Zhang, DaLiao Xiao

PMC · DOI: 10.1016/j.isci.2025.114311 · iScience · 2025-12-05

## TL;DR

This study shows how gestational diabetes affects offspring heart health through FTO protein and RNA methylation, suggesting new treatment approaches.

## Contribution

The study reveals FTO-dependent m6A methylation as a novel mechanism linking gestational diabetes to offspring cardiac dysfunction.

## Key findings

- GDM represses FTO, increasing m6A methylation and causing cardiac hypertrophy in offspring.
- FTO restoration reverses GDM-induced cardiac senescence and mitochondrial defects.
- Targeting the FTO/m6A axis may prevent GDM-related cardiac programming in offspring.

## Abstract

Fat mass and obesity-associated (FTO) protein plays a critical role in N6-methyladenosine (m6A) demethylation, linked to metabolic disorders such as diabetes and obesity. This study investigates FTO-dependent m6A methylation in fetal programming of cardiac dysfunction due to gestational diabetes mellitus (GDM). Using a Sprague-Dawley rat model of GDM, we observed that GDM exposure repressed FTO, increasing m6A RNA methylation, consequently developing a cardiac hypertrophic dysfunctional phenotype in neonatal offspring. FTO inhibition replicated the effects of GDM, while overexpression of FTO via FTO lentivirus (Lenti-FTO) reversed GDM-induced hypertrophy, cardiac senescence, and dysfunction. These results illuminate the molecular mechanisms by which GDM negatively impacts offspring cardiac health and highlight the potential for targeting FTO-mediated RNA methylation pathways as a therapeutic strategy for GDM-related cardiac issues.

•GDM represses cardiac FTO, increasing m6A methylation and hypertrophy in offspring•FTO-dependent m6A regulation links GDM to cardiac dysfunction in neonatal hearts•FTO restoration alleviates GDM-induced cardiac senescence and mitochondrial defects•Targeting the FTO/m6A axis may help prevent GDM-induced cardiac programming

GDM represses cardiac FTO, increasing m6A methylation and hypertrophy in offspring

FTO-dependent m6A regulation links GDM to cardiac dysfunction in neonatal hearts

FTO restoration alleviates GDM-induced cardiac senescence and mitochondrial defects

Targeting the FTO/m6A axis may help prevent GDM-induced cardiac programming

Molecular mechanism of gene regulation; Epigenetics

## Linked entities

- **Genes:** FTO (FTO alpha-ketoglutarate dependent dioxygenase) [NCBI Gene 79068]
- **Proteins:** FTO (FTO alpha-ketoglutarate dependent dioxygenase)
- **Diseases:** gestational diabetes mellitus (MONDO:0005406)

## Full-text entities

- **Diseases:** cardiac dysfunction (MESH:D006331), GDM (MESH:D016640), cardiac senescent hypertrophy and dysfunction (MESH:D006332), diabetes (MESH:D003920), obesity (MESH:D009765), metabolic disorders (MESH:D008659), hypertrophy (MESH:D006984)
- **Chemicals:** N6-methyladenosine (MESH:C010223), m6A (MESH:C005955)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12774703/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12774703/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12774703/full.md

---
Source: https://tomesphere.com/paper/PMC12774703